The patient was a 69-y-old man who, 37 d earlier, had a 4-d-long evolving onset of headache, dizziness, acute personality changes, visual changes, and weakness. Unspecified imaging was obtained at an outside facility, and he was diagnosed with an intracerebral stenosis. Subsequently, he was given aspirin and clopidogrel (Plavix; Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership) and told to return for reevaluation in 1 mo. At the 1-mo follow-up, his physical examination was interpreted as being significant for a Glasgow Coma Scale score of 15, and cranial nerves were intact. His examination was otherwise effectively unremarkable. Laboratory findings were normal. The nuclear medicine department was consulted because there was concern about possible intracerebral stenosis.
A 2-d 99m Tc-exametazime (1,184 and 1,073 MBq [32 and 29 mCi, respectively) baseline SPECT/CT scan, followed 24 h later by a 1-g acetazolamide (Diamox; Teva Pharmaceuticals) challenge SPECT/CT scan, was obtained to evaluate for cerebrovascular abnormalities. A non-contrast-enhanced CT scan was acquired for attenuation correction using a 5-mm slice interval, a low-energy all-purpose filter, a zoom of 2.19, a 273 · 273 field of view, and a 128 · 128 matrix. Emission imaging was obtained with 128 angles, at 25 s per step. Data were processed using ordered-subset expectation maximization (4 iterations, 8 subsets) and a Butterworth filter (cutoff, 2.0; order, 2.53). No sedatives were administered.
On challenge imaging, in comparison to baseline, there was a 30% decrease in radiotracer distribution involving the left cerebral hemisphere. A 30% decrease was calculated by comparing the uptake in the noneffected hemisphere and within the effected hemisphere on a 20-step color scale (where each shade represents a 5% change). A direct comparison was made by counting how many color shades of difference there was and correlating that to the total number of shades available (e.g., there were 6 shades of color difference, on a 20-step scale, which results in a 30% difference). No significant motion was appreciated, and the quality of the images was considered technically adequate. This finding was consistent with a positive acetazolamide-enhanced brain perfusion study, indicating a significant lack of flow reserve to the left cerebral hemisphere. Neurointerventional radiology identified a high-grade stenotic segment of the left supraclinoid ICA measuring approximately 16 mm in length, with a significant flow limitation ( ½Fig: 1 Fig. 1A ). Successful balloon angioplasty of the left supraclinoid ICA was performed (Fig. 1B) . The patient remained on clopidogrel and aspirin, to be followed with contrastenhanced magnetic resonance angiography after 3 mo. 
CASE DISCUSSION
If the patient had not presented with an outside imaging diagnosis of intracerebral stenosis or with such a prodrome before acetazolamide SPECT imaging, other etiologies to include in a differential diagnosis might have been trauma, infection, and neoplasia. After imaging, other etiologies to consider were abnormal presentation of Kawasaki disease, hypertension, and migraine.
Acetazolamide SPECT imaging for neurologic vascular anomaly has been generally performed in many ways, ranging from a single-day split dose to a single-day dual-isotope ( 99m Tc) technique. Most studies use a 2-d challenge first-if the challenge is normal, the test is stopped. In this case, a 2-d 99m Tc-exametazine baseline test was used first, followed by an acetazolamide technique. This procedure was not in accordance with current guidelines of the Society of Nuclear Medicine and Molecular Imaging, but it was supported by a unique clinical situation.
Acetazolamide SPECT imaging for a neurologic vascular anomaly is a valuable tool in a modern nuclear medicine department. Occlusion of the internal carotid artery carries a 30% risk of ischemia of the ipsilateral cerebral hemisphere (4). Neither CT not MR imaging can fully define the physiologically significant flow reserve in a stenotic cerebral vessel. Regardless of the technique, the interpretation of SPECT and SPECT/CT neurologic imaging is user-dependent and can be fraught with pitfalls. Having a solid familiarity with normal regional and side-to-side variation is critical. 99m Tchexamethylpropyleneamine oxime imaging with carotid artery balloon occlusion has shown a discrepancy of at least 10% in side-to-side or regional radiotracer accumulation to be important (4).
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Answers to the Questions on Pages nn and nn
Question 1
Answer 5 A In patients with allergy to sulfonamides, there is significant risk of serious allergic reaction, even life-threatening, with the administration of acetazolamide (1,2). Acetazolamide is a carbonic anhydrase inhibitor, which produces a vasodilatory effect on the cerebral circulation. Similar to pharmacologic myocardial perfusion scintigraphy, a significantly stenosed cerebral vessel is not able to dilate in proportion to the nonstenosed vessels, resulting in a relative low flow state and a relative underperfusion.
Question 2
Answer 5 D There is a 30% decrease in radiotracer distribution to the entire left hemisphere on challenge imaging. This decrease is interpreted as a significant perfusion defect. Examples of SPECT images of regional cerebral blood flow in healthy subjects are available for review at http://brainscans.indd.org. 
